.INVESTIGATION EMPHASIZE.06 August 2024.
A big randomized regulated trial along with cisgender females highlights the problems of obedience to a regular oral preexposure prophylaxis routine as well as demonstrates that twice-yearly injection of lenacapavir may keep helpful HIV protection levels over 6 months.